Cannell & Co. Teleflex Inc Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Teleflex Inc stock. As of the latest transaction made, Cannell & Co. holds 2,800 shares of TFX stock, worth $483,448. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,800

Previous 2,800 -0.0%

Holding current value

$483,448

Previous $549,000 27.14%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$188.57 - $253.75 $1,885 - $2,537	-10 Reduced 0.36%	2,800 $698,000
Q3 2021 Nov 10, 2021	SELL	$360.3 - $422.82 $151,326 - $177,584	-420 Reduced 13.0%	2,810 $1.06 Million
Q2 2021 Aug 09, 2021	SELL	$385.96 - $443.85 $19,298 - $22,192	-50 Reduced 1.52%	3,230 $1.3 Million
Q2 2020 Aug 07, 2020	SELL	$279.8 - $376.58 $2,798 - $3,765	-10 Reduced 0.3%	3,280 $1.19 Million
Q1 2020 May 05, 2020	SELL	$225.31 - $395.14 $22,531 - $39,514	-100 Reduced 2.95%	3,290 $964,000
Q3 2019 Nov 12, 2019	SELL	$329.13 - $371.65 $3,291 - $3,716	-10 Reduced 0.29%	3,390 $1.15 Million
Q2 2019 Aug 12, 2019	SELL	$274.54 - $336.13 $113,934 - $139,493	-415 Reduced 10.88%	3,400 $1.13 Million
Q3 2018 Nov 05, 2018	SELL	$228.13 - $278.9 $3,421 - $4,183	-15 Reduced 0.39%	3,815 $1.02 Million
Q2 2018 Aug 06, 2018	SELL	$246.68 - $284.87 $12,334 - $14,243	-50 Reduced 1.29%	3,830 $1.03 Million
Q1 2018 May 09, 2018	SELL	$242.67 - $287.65 $157,735 - $186,972	-650 Reduced 14.35%	3,880 $989,000
Q4 2017 Feb 13, 2018	SELL	$236.76 - $270.19 $10,654 - $12,158	-45 Reduced 0.98%	4,530 $1.13 Million
Q3 2017 Nov 08, 2017	BUY	$203.01 - $242.56 $928,770 - $1.11 Million	4,575	4,575 $1.11 Million

Others Institutions Holding TFX

# of Institutions

565

Shares Held

45.7M

Call Options Held

18.3K

Put Options Held

10.2K

View Full List

About TELEFLEX INC

Ticker TFX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,906,400
Market Cap $8.1B
Description
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access ...

More about TFX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account